BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹92 Cr | ₹100 Cr | ₹94 Cr | ₹75 Cr | ₹67 Cr |
What is the latest Sundry Debtors ratio of BAL PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹92 Cr |
| Mar2024 | ₹100 Cr |
| Mar2023 | ₹94 Cr |
| Mar2022 | ₹75 Cr |
| Mar2021 | ₹67 Cr |
How is Sundry Debtors of BAL PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹92 Cr | -7.21 | |
| Mar2024 | ₹100 Cr | 6.01 | |
| Mar2023 | ₹94 Cr | 24.78 | |
| Mar2022 | ₹75 Cr | 12.08 | |
| Mar2021 | ₹67 Cr | - | |
Compare Sundry Debtors of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹122.0 Cr | 7.2% | 5.1% | -35.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -0.4% | -0.1% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,363.0 Cr | 0.9% | -3% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,193.0 Cr | 2% | 1.7% | 25.2% | Stock Analytics | |
| CIPLA | ₹109,519.0 Cr | -0.9% | -7.2% | -9.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,940.0 Cr | -0.6% | 6.8% | 2.7% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 7.2% |
5.1% |
-35.2% |
| SENSEX | -0.9% |
-0.1% |
7% |
You may also like the below Video Courses